Steven Leonard Chapman - 03 Nov 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
03 Nov 2025
Net transactions value
-$14,071,497
Form type
4
Filing time
03 Nov 2025, 21:40:05 UTC
Previous filing
29 Oct 2025
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chapman Steven Leonard CEO AND PRESIDENT, Director C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN /s/ Vincent Fontanilla, Attorney-in-Fact 03 Nov 2025 0001711968

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $27,113 +2,084 +1.4% $13.01 151,924 03 Nov 2025 Direct
transaction NTRA Common Stock Options Exercise $72,871 +3,595 +2.4% $20.27 155,519 03 Nov 2025 Direct
transaction NTRA Common Stock Options Exercise $17,962,500 +150,000 +96% $119.75 305,519 03 Nov 2025 Direct
transaction NTRA Common Stock Sale $438,635 -2,215 -0.72% $198.03 303,304 03 Nov 2025 Direct F1, F2
transaction NTRA Common Stock Sale $381,012 -1,915 -0.63% $198.96 301,389 03 Nov 2025 Direct F1, F3
transaction NTRA Common Stock Sale $31,314,334 -156,573 -52% $200.00 144,816 03 Nov 2025 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -2,084 -100% $0.000000 0 03 Nov 2025 Common Stock 2,084 $13.01 Direct F5
transaction NTRA Stock Option (right to buy) Options Exercise $0 -3,595 -100% $0.000000 0 03 Nov 2025 Common Stock 3,595 $20.27 Direct F5
transaction NTRA Stock Option (right to buy) Options Exercise $0 -150,000 -100% $0.000000 0 03 Nov 2025 Common Stock 150,000 $119.75 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The sale of 150,000 of these shares was governed by the initial plan and not altered by the subsequently amendment.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.28 to $198.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.44 to $199.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.51 to $200.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The option shares are fully exercisable.
F6 On January 22, 2021, the Reporting Person was granted performance-based options which vest in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. The performance thresholds were certified on June 28, 2024, March 28, 2025 and September 28, 2025, resulting in the performance-based option being fully vested as of the last performance threshold date.